Companion Animal Welfare

Cat Feline Gingivostomatitis Stem Cell Therapy

Emerging stem cell therapy for feline gingivostomatitis offers a new treatment option for cats who fail conventional management.

Key Facts

Adipose-derived mesenchymal stem cells have shown promise in FCGS case series
Immunomodulatory effects of stem cells may address the underlying immune dysregulation
Treatment requires stem cell harvest and processing before IV administration
Current evidence is based on case series rather than randomised controlled trials
Cost and availability limit access but research is advancing rapidly

Welfare Considerations

For cats with treatment-resistant gingivostomatitis who fail extraction-based management, emerging stem cell therapy offers a new welfare option. The immunomodulatory potential to address root cause immune dysregulation represents a genuinely novel approach.

What You Can Do

Ask your specialist about eligibility for stem cell therapy trials if extraction fails to resolve FCGS
Support institutions conducting FCGS stem cell therapy research
Follow emerging clinical evidence for new FCGS treatments through veterinary publications